Safety and Efficacy of Brimonidine Tartrate Posterior Segment Drug Delivery System in Improving Visual Function

Rhegmatogenous Macula-off Retinal Detachment Clinical Trial

Status Completed

Clinical Trial Summary

This study will evaluate the efficacy and safety of the Brimo PS DDS® Applicator System (200 μg and 400 μg brimonidine tartrate) on visual function in patients with previous rhegmatogenous macula-off retinal detachment.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Retinal Detachment
• Rhegmatogenous Macula-off Retinal Detachment

• NCT number: NCT00972374
• Study type: Interventional
• Source: Allergan
• Status: Completed
• Phase: Phase 2
• Start date: November 2009
• Completion date: July 2011